The site of betaine’s action in normalizing insulin resistance appears to be at the level of tyrosine phosphorylation of IRS1, but not at the phosphorylation of insulin receptor nor at the amount of insulin receptor. The gene discussed is INSR; the disease is Insulin resistance.